Morrell Martha 4

What Happened
Martha Morrell, Chief Medical Officer of NeuroPace, had 3,412 shares disposed on February 20, 2026 as a tax-withholding action related to the vesting of restricted stock units. The filing reports the shares were withheld at an implicit price of $14.34 per share, for a total value of approximately $48,928. This disposition was to satisfy tax withholding obligations (transaction code F), not an open-market sale initiated for investment reasons.

Key Details

• Transaction date and price: 02/20/2026; 3,412 shares at $14.34 per share; total value reported $48,928.
• Transaction type: F — shares withheld to satisfy tax withholding on RSU vesting (per footnote F1).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing date: 02/23/2026 (covers the 02/20/2026 transaction); no late filing indicator noted in the provided data.

Context
Tax-withholding dispositions on vested RSUs are routine and are often handled by the company withholding a portion of shares rather than the insider selling shares on the open market. Such withholdings are administrative and do not necessarily signal the insider's view of the company’s prospects.